@ernestoiadanza, prof. in #ClinicalEngineering at @UNI_FIRENZE and chair of the @IFMBE_HTAD, explains the importance of the risk assessment in the development of #medicaldevices @uborabiomedical https://t.co/FTTWVBqCqt
— IFMBE_HTAD (@IFMBE_HTAD) November 6, 2018